MENU
+Compare
RMD
Stock ticker: NYSE
AS OF
Dec 24 closing price
Price
$244.44
Change
-$0.16 (-0.07%)
Capitalization
35.68B

RMD ResMed Forecast, Technical & Fundamental Analysis

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more

RMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RMD with price predictions
Dec 24, 2025

RMD sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for RMD moved below the 200-day moving average on December 23, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RMD as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RMD turned negative on December 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RMD entered a downward trend on December 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RMD advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

RMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.828) is normal, around the industry mean (9.534). P/E Ratio (25.019) is within average values for comparable stocks, (167.335). Projected Growth (PEG Ratio) (1.578) is also within normal values, averaging (2.546). Dividend Yield (0.009) settles around the average of (0.017) among similar stocks. P/S Ratio (6.845) is also within normal values, averaging (112.419).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

View a ticker or compare two or three
RMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RMD is expected to report earnings to rise 6.67% to $2.72 per share on January 22

ResMed RMD Stock Earnings Reports
Q4'25
Est.
$2.72
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Beat
by $0.11
The last earnings report on October 30 showed earnings per share of $2.55, beating the estimate of $2.52. With 201.33K shares outstanding, the current market capitalization sits at 35.68B.
A.I.Advisor
published Dividends

RMD paid dividends on September 18, 2025

ResMed RMD Stock Dividends
А dividend of $0.60 per share was paid with a record date of September 18, 2025, and an ex-dividend date of August 14, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of devices for evaluation and treatment of sleep disorders

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PGX11.240.03
+0.27%
Invesco Preferred ETF
LJAN24.720.05
+0.21%
Innovator Premium Income 15 Buf ETF -Jan
LSAF45.960.08
+0.19%
LeaderSharesTM AlphaFactor® US Cr Eq ETF
LITL29.96N/A
N/A
Simplify Piper Sandler Us Small-Cap Plus Income ETF
IGLD26.30-0.07
-0.27%
FT Vest Gold Strategy Trgt Inc ETF

RMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-0.07%
SOLV - RMD
52%
Loosely correlated
-0.46%
BLCO - RMD
46%
Loosely correlated
+0.18%
NVST - RMD
44%
Loosely correlated
+0.59%
ALC - RMD
42%
Loosely correlated
+0.06%
COO - RMD
40%
Loosely correlated
-0.37%
More

Groups containing RMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-0.07%
Pharmaceuticals: Other
industry (102 stocks)
51%
Loosely correlated
+0.30%
Pharmaceuticals
industry (375 stocks)
50%
Loosely correlated
+0.36%